✦ LIBER ✦

Phase II double-blind randomized study of lonidamine and radiotherapy in epidermoid carcinoma of the lung

✍ Scribed by Privitera, Giuseppe; Ciottoli, Giovanni Battista; Patanè, Carmelo; Palmucci, Tullio; Tafuri, Gaetano; Marletta, Francesco; De Luca, Bruno; Magnani, Francesco; De Gregorio, Mauro; Greco, Stefano

Book ID: 123259488
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 452 KB
Volume: 10
Category: Article
ISSN: 0167-8140
DOI: 10.1016/S0167-8140(87)80034-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiotherapy of regional epidermoid carc

Radiotherapy of regional epidermoid carcinoma of the lung: A study in fractionation

✍ Rossall Sealy; Stephen Lagakos; Thomas Barkley; Roger Ryall; Robert D. Tucker; R 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 663 KB

Phase II study of lonidamine plus radiot

Phase II study of lonidamine plus radiotherapy in the treatment of brain metastases

✍ David J. Stewart; Libni Eapen; Andre Girard; Shailendra Verma; Paul Genest; Will 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 264 KB

Gefitinib plus cisplatin and radiotherap

Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell carcinoma: A phase II, randomized, double-blind, placebo-controlled study

✍ Vincent Gregoire; Marc Hamoir; Changhu Chen; Madeleine Kane; Andrzej Kawecki; Pr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Misonidazole combined with radiotherapy

Misonidazole combined with radiotherapy in the treatment of inoperable squamous cell carcinoma of the lung a double-blind randomized trial

✍ Jytte Panduro; Mogens Kjaer; Jacob Wolff-Jensen; Heine H. Hansen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

S-fluoxetine in the prophylaxis of migra

S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study

✍ TJ Steiner; F Ahmed; LJ Findley; EA MacGregor; M Wilkinson 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 584 KB

6518 Evaluation of vandetanib in patient

6518 Evaluation of vandetanib in patients with inoperable hepatocellular carcinoma (HCC): a randomized, double-blind, parallel group, multicentre, Phase II study

✍ Hsu, C.; Yang, T.S.; Huo, T.L.; Hsieh, R.K.; Hwang, W.S.; Hsieh, T.Y.; Huang, W. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB